Stocktoria
NRC HEALTH NRC
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 1997-10-01
NRC HEALTH statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 16.4% | 24.6% | 27.0% | 30.7% | 34.0% |
| FCF margin | 11.5% | 13.4% | 15.0% | 17.4% | 27.6% |
| Debt / equity | 5.36× | 1.85× | 0.75× | 0.31× | 0.31× |
| Current ratio | 0.55 | 0.55 | 0.67 | 1.31 | 1.82 |
| Revenue growth | -4.0% | -3.7% | -2.0% | 2.4% | 11.0% |
Source: SEC EDGAR filings · CIK 0000070487 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.